CAJ | 학술논문

目的观察注射技术治疗急性特发性面神经麻痹的临床疗效.方法选取符合标准的126例急性期特发性面神经麻痹患者,将其随机分为治疗组90例和对照组36例.两组均每日给予神经生长因子18μg肌注与β-七叶皂苷钠15mg静脉滴注,治疗组还采用局部注射技术治疗.治疗4周后采用House-Brackmann(H-B)面神经功能评价分级系统进行疗效评价.结果治疗后两组组间H-B分级量表比较差异显著(P<0.01).治疗组总有效率为96.7%,对照组为80.6%,两组比较差异显著(P<0.05).结论注射技术治疗急性期特发性面神经麻痹临床疗效显著,在临床中值得进一步推广.
목적관찰주사기술치료급성특발성면신경마비적림상료효.방법선취부합표준적126례급성기특발성면신경마비환자,장기수궤분위치료조90례화대조조36례.량조균매일급여신경생장인자18μg기주여β-칠협조감납15mg정맥적주,치료조환채용국부주사기술치료.치료4주후채용House-Brackmann(H-B)면신경공능평개분급계통진행료효평개.결과치료후량조조간H-B분급량표비교차이현저(P<0.01).치료조총유효솔위96.7%,대조조위80.6%,량조비교차이현저(P<0.05).결론주사기술치료급성기특발성면신경마비림상료효현저,재림상중치득진일보추엄.
Objective: To observe the clinical efficacy of injection technology in the treatment of acute idiopathic facial paralysis.Methods: 126 cases with acute idiopathic facial paralysis were randomly divided into treatment group (90 cases)and control group (36 cases). Both groups were given daily intramuscular nerve growth factor 18μg and intravenous Aescine sodium 15mg, in addition the treatment group was treated with local injection technology. After 4 weeks’ treatment, evaluated the efficacy by House-Brackmann (HB) facial nerve function grading system. Results: The differences of the HB rating scale between the two groups after treatment were statisticaly significant (P<0.01); The total effective rate was 96.7% in the treatment group, 80.6% in the control group. The difference was statisticaly significant between the two groups (P<0.05). Conclusion:Injection technology has obvious therapeutic effect and significant clinical efficacy was worthy of further application of the clinics in treating idiopathic facial paralysis.